2019
DOI: 10.1111/dth.12900
|View full text |Cite
|
Sign up to set email alerts
|

Hypersensitivity reaction to certolizumab pegol in a patient affected by psoriatic arthritis

Abstract: The pathogenic mechanism of hypersensitivity reactions (HSRs) to monoclonal antibodies is not fully understood. HSRs can occur after the first exposure or multiple exposures and include acute infusion reactions induced by cytokine release, besides Type I, Type III, and Type IV reactions.). We reported a case of anaphylactic reaction to certolizumab pegol in a patient affected by psoriatic arthritis and a possible management of this condition.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 9 publications
0
1
0
Order By: Relevance
“…Adverse effects, including paradoxical psoriasiform eruptions or hypocomplementemic urticaria-vasculitis have been reported [2,3]. Besides, hypersensitivity reactions after CZP administration have been described, both to the anti-TNF portion of the antibody and to the PEG component [4,5].…”
mentioning
confidence: 99%
“…Adverse effects, including paradoxical psoriasiform eruptions or hypocomplementemic urticaria-vasculitis have been reported [2,3]. Besides, hypersensitivity reactions after CZP administration have been described, both to the anti-TNF portion of the antibody and to the PEG component [4,5].…”
mentioning
confidence: 99%